George Boon‐Bee Goh

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne et al. · Hepatology International · 2023 · 163 citations · Full text

Preventive Medicine, Cardiovascular Disease, Disease Risk Assessment +9

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

Huapeng Lin, Hye Won Lee, Terry Cheuk‐Fung Yip et al. · JAMA · 2024 · 163 citations · Full text

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien et al. · Alimentary Pharmacology & Therapeutics · 2020 · 150 citations · Full text

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

Arun J. Sanyal, Patricia López, Eric Lawitz et al. · Nature Medicine · 2023 · 146 citations · Full text